| E-Folder |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Internet and Businesses Online > Banner Advertising > Banner Glossary |
|
E-Folder - Banner Glossary
• Banner Ad — A graphic ad linked to an advertiser’s website. These usually run across the top of the page but c According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product an also run up the page (“skyscrapers”). Banners are usually limited by size. • Banner Views —The number of tim ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in es a banner is seen by users. This is usually the same as "page views," but counts the number of times the banne lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. r is actually downloaded rather than the number of times the page is downloaded. Some users click away before th here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe e banner finishes loading. • Clicks/ Click Throughs — Banners are operated by clicking the cursor over them. No d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro t too surprisingly these responses are called “clicks” or “click throughs.” • Click Through Rate (CTR) — The pe ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc rcentage of users who see the banner and click on it. • Conversion Rate —The percentage of people who visit you easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi r site and actually give you money. The higher the better! • Cookies — Small files placed on a user’s computer. nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically They’re used for all sorts of reasons and by all sorts of sites. Banner ads use them to make sure the user hasn and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ ’t seen the banner recently, which banner brought them to the advertiser’s site, and even which adverts they’ve ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi seen recently. • CPM — "Cost Per Mille." The amount you pay for every thousand times a banner is shown—the usua ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a l way of charging for banners. • Hits — The number of times a server receives a request for a Web page or an im dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod age. Not a great way to measure interest. One page can have lots of images and get lots of hits, even if it’s on cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin ly seen once. Often, people will say "hits" when they really mean "page views" or "impressions." • Page Impress tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen ions or Page Views —The number of times a Web page has been requested by the server. Much more accurate than hit t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel s: each view is a potential customer looking at a page of your site. But not necessarily a different customer... ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust • Unique Users — The people who download a Web page, counted by IP address. You want to bring lots of users t y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products o your site so that you can create a broad customer base. The same user clicking on a banner a dozen times could . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de cost you money without increasing your sales. Most reputable sites will check the IP address of the person clic elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip king on a link and only count it once in a 24-hour period. If a site doesn’t do this, don’t advertise with them. tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Franchise Territories for Mobile Businesses; Why Limitations Productive Internet and Online Business - Steps to Edge into an Internet and Online Business Use a Free eBook as Your Sales Weapon for Viral Residual Affiliate Income
|